Krug A - Search Results

1

Specific suppression of human tumor necrosis factor-alpha synthesis by antisense oligodeoxynucleotides.

Hartmann G, Krug A, Eigler A, Moeller J, Murphy J, Albrecht R, Endres S. Hartmann G, et al. Among authors: krug a. Antisense Nucleic Acid Drug Dev. 1996 Winter;6(4):291-9. doi: 10.1089/oli.1.1996.6.291. Antisense Nucleic Acid Drug Dev. 1996. PMID: 9012865

2

Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin.

Hartmann G, Krug A, Waller-Fontaine K, Endres S. Hartmann G, et al. Among authors: krug a. Mol Med. 1996 Jul;2(4):429-38. Mol Med. 1996. PMID: 8827713 Free PMC article.

3

Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes.

Hartmann G, Krug A, Bidlingmaier M, Hacker U, Eigler A, Albrecht R, Strasburger CJ, Endres S. Hartmann G, et al. Among authors: krug a. J Pharmacol Exp Ther. 1998 May;285(2):920-8. J Pharmacol Exp Ther. 1998. PMID: 9580645

4

Shock waves: a novel method for cytoplasmic delivery of antisense oligonucleotides.

Tschoep K, Hartmann G, Jox R, Thompson S, Eigler A, Krug A, Erhardt S, Adams G, Endres S, Delius M. Tschoep K, et al. Among authors: krug a. J Mol Med (Berl). 2001 Jun;79(5-6):306-13. doi: 10.1007/s001090100204. J Mol Med (Berl). 2001. PMID: 11485025

5

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.

Krug A, Rothenfusser S, Hornung V, Jahrsdörfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM, Hartmann G. Krug A, et al. Eur J Immunol. 2001 Jul;31(7):2154-63. doi: 10.1002/1521-4141(200107)31:7<2154::aid-immu2154>3.0.co;2-u. Eur J Immunol. 2001. PMID: 11449369 Free article.

6

Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.

Jahrsdörfer B, Jox R, Mühlenhoff L, Tschoep K, Krug A, Rothenfusser S, Meinhardt G, Emmerich B, Endres S, Hartmann G. Jahrsdörfer B, et al. Among authors: krug a. J Leukoc Biol. 2002 Jul;72(1):83-92. J Leukoc Biol. 2002. PMID: 12101266

7

Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta.

Rothenfusser S, Hornung V, Krug A, Towarowski A, Krieg AM, Endres S, Hartmann G. Rothenfusser S, et al. Among authors: krug a. Eur J Immunol. 2001 Dec;31(12):3525-34. doi: 10.1002/1521-4141(200112)31:12<3525::aid-immu3525>3.0.co;2-5. Eur J Immunol. 2001. PMID: 11745372 Free article.

8

Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.

Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, Giese T, Engelmann H, Endres S, Krieg AM, Hartmann G. Krug A, et al. Eur J Immunol. 2001 Oct;31(10):3026-37. doi: 10.1002/1521-4141(2001010)31:10<3026::aid-immu3026>3.0.co;2-h. Eur J Immunol. 2001. PMID: 11592079 Free article.

9

[Specific modification of the immune system with CpG-oligonucleotides].

Krug A, Hartmann G. Krug A, et al. Dtsch Med Wochenschr. 2001 Sep 14;126(37):1002-4. doi: 10.1055/s-2001-17110. Dtsch Med Wochenschr. 2001. PMID: 11555774 Review. German. No abstract available.

10

Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization.

Lemke-Miltner CD, Blackwell SE, Yin C, Krug AE, Morris AJ, Krieg AM, Weiner GJ. Lemke-Miltner CD, et al. J Immunol. 2020 Mar 1;204(5):1386-1394. doi: 10.4049/jimmunol.1900742. Epub 2020 Jan 17. J Immunol. 2020. PMID: 31953355 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters